AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04036006 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Directed Program
Description: The Self-Directed lifestyle program represents enhanced usual care based upon what is currently offered in primary care in the United States for lifestyle treatments for adults with metabolic syndrome. Usual care is enhanced by: 1) lifestyle education for management of metabolic syndrome provided in evidence-based tip sheets from nationally recognized organizations; 2) provision of a Fitbit for self-monitoring physical activity; 3) access to a website containing all education materials; and 4) progress report letters with lab results sent to participants and primary care physicians after completion of each assessment.
Study NCT02278159 — intervention group
Intervention type: PROCEDURE
Intervention: Peritoneal dialysis
Study NCT02278159 — intervention group
Intervention type: PROCEDURE
Intervention: Home hemodialysis
Study NCT00657839 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levitra (Vardenafil, BAY38-9456)
Description: 10 mg Vardenafil bid
Study NCT02462200 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Breast-conserving surgery (BCS)
Study NCT02462200 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery (BCS)
Study NCT02462200 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cavity shave margins (CSM)
Study NCT02462200 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BREAST-Q Questionnaire
Study NCT02462200 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BREAST-Q Questionnaire
Study NCT02462200 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3-D breast imaging
Description: Using a 3-D breast imaging camera Vectra 3-D XT
Study NCT02462200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3-D breast imaging
Description: Using a 3-D breast imaging camera Vectra 3-D XT
Study NCT02462200 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Indocyanine green
Study NCT02462200 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Indocyanine green
Study NCT02462200 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intraoperative imaging device
Description: The goggle device is wearable, compact, and battery-operated, and it allows for hands-free operation by the wearer. The goggles provide functional information via a NIR light-emitting diode (LED) integrated within one of the eyepieces, which causes NIR fluorescence excitation of the molecular probes within the surgical field
Study NCT02462200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intraoperative imaging device
Description: The goggle device is wearable, compact, and battery-operated, and it allows for hands-free operation by the wearer. The goggles provide functional information via a NIR light-emitting diode (LED) integrated within one of the eyepieces, which causes NIR fluorescence excitation of the molecular probes within the surgical field
Study NCT02462200 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral blood draw
Description: -Time of surgery if coordinator is available
Study NCT00657839 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT04899375 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Floss band
Description: Tissue-flossing, is the use of an elastic band to provide compression on soft-tissue and joints whilst performing active and, or passive range of motion.
Study NCT02462200 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral blood draw
Description: -Time of surgery if coordinator is available
Study NCT00695318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide
Description: 0.2 µg/Day in study eye + Sham in fellow eye
Study NCT00695318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide
Description: 0.5 µg/Day in study eye +Sham in fellow eye
Study NCT01054339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rAAV1-CB-hAAT
Description: Recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin
Study NCT02068833 — intervention group
Intervention type: PROCEDURE
Intervention: Gastrectomy
Study NCT02068833 — intervention group
Intervention type: PROCEDURE
Intervention: BPD-DS
Study NCT04358666 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgery and focal radiosurgery of the surgical bed
Description: hypofractionned radiosurgery of the lesion
Study NCT03724799 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood for the patients with cerebral infarction
Description: Intravenous low level therapy has been a variety of applications in many different areas of medicine with a growing interest. It possesses laser specific biomodulation, analgesic, spasmolytic and even sedative effects among many other.
Study NCT04899375 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACE bandage
Description: An ACE bandage is a cloth wrap used to provide compression
Study NCT04160247 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate implant placement
Description: Implants are placed in fresh socket
Study NCT04160247 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Immediate implant placement
Description: Implants are placed in fresh socket
Study NCT04160247 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Angulated screw-retained crowns placement
Description: To insert the restorations by angulated screw systems
Study NCT02036476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: oral administration
Study NCT00430924 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eplerenone
Description: Once daily administration for 8 weeks and 8 weeks control.
Study NCT00430924 — intervention group
Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: Eplerenone
Description: Once daily administration for 8 weeks and 8 weeks control.
Study NCT02499172 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Shanchol
Study NCT02371980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Description: Vortioxetine capsules
Study NCT02371980 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vortioxetine
Description: Vortioxetine capsules
Study NCT04257916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Myofascial technique intervention of the subastragalar joint, kinesiotape and eccentric training with isoinercial machine. The intervention lasted 4 weeks. Each treatment session lasted 50 minutes, with 2 sessions a week. Between training sessions, the indicated break was 48 hours.
Study NCT04257916 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual therapy group
Description: Myofascial technique of the subastragalar joint and eccentric training with isoinercial machine. The intervention lasted 4 weeks. Each treatment session lasted 50 minutes, with 2 sessions a week. Between training sessions, the indicated break was 48 hours.
Study NCT05409170 — intervention group
Intervention type: PROCEDURE
Intervention: COVID
Description: Each surgical procedure was considered an independent event. Moreover, the January 2016-December 2019 and January 2020-December 2021 intervals were defined as pre-COVID and COVID periods, respectively.
Study NCT02371980 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vortioxetine placebo-matching capsules
Study NCT01719042 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zofran (8mg)
Description: Subject will take 8mg of Zofran before taking antibiotic regimen and will record symptoms in a diary just before taking medication and two hours after taking medication every day for two weeks
Study NCT01719042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Ensure
Description: Subject will drink one cam of Ensure before taking antibiotic regimen and will record symptoms in a diary just before taking medication and two hours after taking medication every day for two weeks
Study NCT00221065 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal Continuous positive airway pressure - Tyco 420G
Description: CPAP at determined pressure nightly for 1 month
Study NCT04160247 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Cemented crowns placement
Description: To cement the restorations onto the implant abutment
Study NCT04525924 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bright light therapy
Description: please see arm description
Study NCT04360512 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posteriorization of the talus
Description: Three sets of a 30-s grade IV mobilization
Study NCT01385111 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: EUS-B-FNA followed by EBUS-TBNA
Description: EUS-B-FNA will be performed followed by EBUS-TBNA when additional needle aspiration is necessary after EBUS-TBNA.
Study NCT01385111 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EBUS-TBNA followed by EUS-B-FNA
Description: EBUS-TBNA will be performed followed by EUS-B-FNA when additional needle aspiration is necessary after EUS-B-FNA
Study NCT03908190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Support for Progress
Description: Participants will receive the Personalized Support for Progress Intervention from a peer support provider including sessions with the peer support provider to complete a prioritization task, develop a personalized care plan, and receive support for implementing the personalized care plan.
Study NCT03946982 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: low thoracic epidural
Description: obstetric epidural catheters inserted at low thoracic intervertebral spaces
Study NCT03946982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: low thoracic epidural
Description: obstetric epidural catheters inserted at low thoracic intervertebral spaces
Study NCT03946982 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: lumbar epidural
Description: obstetric epidural catheters inserted at low thoracic intervertebral spaces (conventional)
Study NCT03717207 — intervention group
Intervention type: OTHER
Intervention: ecg Holter,
Description: all patients before to perform an head up tilt test for syncope evaluation will be steadied by ecg Holter to assess heart rate, heart rate variability.
Study NCT02340182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: 250mg 3dd2
Study NCT02340182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Description: 500mg 2dd1
Study NCT02340182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: 500mg 3dd1
Study NCT03812185 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Suctioning orogastric tube which is attached to TEE probe cover
Description: Suctioning orogastric tube which is atttached to TEE probe cover.
Study NCT04427995 — intervention group
Intervention type: DEVICE
Intervention: OMNI surgical system
Description: GATT + viscodilation
Study NCT03640052 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: Placebo capsule before sleep
Study NCT03640052 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LTM1201L
Description: LTM1201L capsule before sleep
Study NCT03640052 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LTM1201LN
Description: LTM1201LN capsule before sleep
Study NCT03640052 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LTM1201LB
Description: LTM1201LB capsule before sleep
Study NCT03640052 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LTM1201LD
Description: LTM1201LD capsule before sleep
Study NCT00849706 — intervention group
Intervention type: OTHER
Intervention: Study participants will work their regular shifts, and tested after night shifts.No shifts will be added because of the study.
Description: Night shifts in our medical center are working 8 hours from 23:00 to 7:00 the following day for nurses, and working overnight (24h) for doctors.
Study NCT05362227 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Low volume macrogol
Description: Clensia 2 lt
Study NCT05362227 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: High volume macrogol
Description: Selg 4 lt
Study NCT01138631 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Embryoscope
Description: The embryoscope is an incubator with in-built photographic equipment
Study NCT02070692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: 7 day course of tamoxifen during an episode of irregular vaginal bleeding
Study NCT02070692 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 7 day course of placebo during an episode of irregular vaginal bleeding
Study NCT03717207 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac scintigraphy
Description: all patients before to perform an head up tilt test for syncope evaluation will receive a the 123I-MIBG, which is a norepinephrine analogous, to calculate the late heart-to-mediastinum ratio (H/Mlate) and washout rate (WR). Thus, we evaluated the H/Mlate as the index of global neuronal function due to norepinephrine uptake and the WR as the index of sympathetic tone.
Study NCT00312390 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Flicker
Study NCT00312390 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Retinal Vessel Diameter
Study NCT00312390 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Retinal Blood Flow
Study NCT04236297 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: bite block
Description: Physicians performing transesophageal echocardiogram in patients under sedation or general anesthesia will use either standard or modified bite block.
Study NCT03154736 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Individual interview and group interview Socio-economic questionnaire
Study NCT02322424 — intervention group
Intervention type: PROCEDURE
Intervention: pancreaticoduodenectomy
Study NCT04257799 — intervention group
Intervention type: OTHER
Intervention: Structured Light Imaging (SLI) System
Description: Investigation of SLI and Tomographic Imaging to see if they will identify cancer cells at the edge of tissue specimens removed during the operation.
Study NCT02234141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablet administered orally once daily
Study NCT02234141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selonsertib
Description: Tablets administered orally once daily
Study NCT03042533 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Compression
Description: Method of Nail fitting
Study NCT03042533 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Backslapping
Description: Method of Nail fitting
Study NCT03042533 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Locking with Backslapping
Description: Method of Nail fitting
Study NCT04090827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse-led transition intervention and access to the iHeartChange website
Description: Elements of the transition interventions include: (i) introduction to transition and its importance, (ii) creation of a MyHealth Passport, (iii) review diagram of participant's cardiac anatomy, (iv) discussion of 3 potential future cardiac complications (v) iHeartChange website (vi) discussion of the concept of self-management (vii) discussion and promotion of communication skills by the adolescent with their healthcare team via the GLADD technique (Give, Listen, Ask, Decide, Do) (viii) a 3-sentence summary about their CHD (ix) ongoing text/email support from RN
Study NCT02266745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PT-112 Injection
Study NCT00908895 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radio-radial fixator
Description: Using the Distal Radius Fixator from Synthes. A single splint for 5 days.
Study NCT00908895 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous pinning
Description: Insert two K-wires in the distal radius, one in the fracture line dorsally and one from the styloid. A cast for 6 weeks.
Study NCT04118673 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Prescription (LRx)
Description: Standard care during consultations with the addition of a physical lifestyle prescription
Study NCT04473495 — intervention group
Intervention type: DEVICE
Intervention: educational video
Description: educational video before intervention
Study NCT00742391 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PEP005 (ingenol mebutate) Gel
Description: two day treatment
Study NCT04165187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Body Awareness Therapy
Description: Body scanning, stretch-release movements, centralization, contact with the ground, postural stability, movement flow and free breathing will be performed during sessions in lying, sitting and standing positions.
Study NCT04165187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home exercise program
Description: Home exercise program will consist of joint range of motion, stretching, strengthening and proprioceptive exercises for lower extremity.
Study NCT04701372 — intervention group
Intervention type: BEHAVIORAL
Intervention: Exposure and response prevention therapy
Description: Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by licensed therapists remotely via video. The treatment was augmented by between-session text messaging and online community support.
Study NCT00742391 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle gel
Description: two day treatment
Study NCT03148249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interview
Description: control group: interview, study group: explanation and exploration
Study NCT00388128 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Caffeine 6mg/kg
Description: Capsules of caffeine 6 mg/kg, taken orally at each test. Before and after treadmill testing
Study NCT02814799 — intervention group
Intervention type: OTHER
Intervention: bone removal
Study NCT03756285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD4831
Description: AZD4831 tablet taken orally for 90 days.
Study NCT03756285 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet taken orally for 90 days.
Study NCT00790491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: guidance tool for providers for lifestyle changes
Description: automated guidance tool for medical providers involved in patient encounters addressing lifestyle changes. Addresses dietary and physical activity. Seeks to reduce cardiac disease risk.
Study NCT02261246 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spinal manipulation treatment
Description: Up to 4 sessions of spinal manipulation treatment (once per week).
Study NCT02882451 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: pinaverium bromide
Study NCT02882451 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin C
Study NCT04389931 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Lactose tab
Description: Two tablets containing lactose Procedure: Periodontal treatment Scaling and root planning
Study NCT04389931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega 3
Description: Two tablets containing 1g Omega 3. Procedure:Periodontal treatment Scaling and root planning
Study NCT02282774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% lidocaine and 0.5% bupivacaine
Description: Under general anesthesia and the operating microscope, a Lieberman lid speculum was placed and the conjunctiva was cleaned with 4% povidone iodine solution. The surgeon then created a fornix-based incision through conjunctiva and tenon's tissue inferonasally midway between the insertions of the medial and inferior rectus muscles, with blunt Wescott scissors to expose the scleral surface before tunneling posteriorly with curved Stevens scissors to create a small channel to the posterior subtenon space. A blunt-tipped subtenon cannula was then inserted into the posterior subtenon space, 4mL of 2% lidocaine and 0.5% bupivacaine (50:50) mixture versus saline was introduced and the drug solution was injected slowly into the subtenon space. After administration of local anesthetic mixture, the eyelid was gently taped down, and no ocular massage was performed
Study NCT02282774 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham subtenon block
Study NCT00681902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: Jet lidocaine compared to jet placebo before needle insertion
Study NCT00681902 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Jet saline